| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159–2167
8 auth. C. Wysham, T. Blevins, R. Arakaki, G. Colon, P. García, C. Atisso, ...
In the print version of the article cited above, a footnote was omitted with respect to antidrug antibodies (ADAs) in Table 2. Exenatide values reported in the last row in Table 2 are not treatment-emergent ADAs; they are total reported ADAs. The la…
In the print version of the article cited above, a footnote was omitted with respect to antidrug antibodies (ADAs) in Table 2. Exenatide values reported in the last row in Table 2 are not treatment-emergent ADAs; they are total reported ADAs. The last three rows of Table 2 should have appeared as …
Published in
Diabetes Care
|
16
|
7 | 2014 |
Social Media Posts